Basics |
Company: |
Altimmune, Inc. |
IPO Date: |
May 22, 2017 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$453.06M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.32 | 4.20%
|
Avg Daily Range (30 D): |
$0.15 | 2.16%
|
Avg Daily Range (90 D): |
$0.25 | 3.24%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.64M |
Avg Daily Volume (30 D): |
1.99M |
Avg Daily Volume (90 D): |
2.61M |
Trade Size |
Avg Trade Size (Sh.): |
155 |
Avg Trade Size (Sh.) (30 D): |
137 |
Avg Trade Size (Sh.) (90 D): |
141 |
Institutional Trades |
Total Inst.Trades: |
1,309 |
Avg Inst. Trade: |
$1.78M |
Avg Inst. Trade (30 D): |
$.87M |
Avg Inst. Trade (90 D): |
$1.03M |
Avg Inst. Trade Volume: |
.18M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.09M |
Avg Closing Trade (30 D): |
$.88M |
Avg Closing Trade (90 D): |
$1.06M |
Avg Closing Volume: |
223.5K |
|
|
|
|
News |
Jan 30, 2025 @ 4:03 PM
Sprout Social, Altimmune, Equinix, and Globe Life ...
Source: Johnson Fistel, Llp
|
Dec 19, 2024 @ 11:35 PM
Why Altimmune Was Such a Robustly Healthy Stock on...
Source: Eric Volkman
|
Nov 15, 2024 @ 4:00 PM
Altimmune Presents New Data on the Effect of Pemvi...
Source: Altimmune, Inc.
|
Sep 17, 2024 @ 2:15 PM
Prediction: This Will Be the First Healthcare Stoc...
Source: The Motley Fool
|
Aug 15, 2024 @ 1:48 PM
Prediction: This Company Will Disrupt Eli Lilly an...
Source: Adam Spatacco
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-1.57
|
$-.32
|
$-.35
|
Diluted EPS
|
$-1.57
|
$-.32
|
$-.35
|
Revenue
|
$ .05M
|
$ .01M
|
$ .01M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -103.52M
|
$ -22.85M
|
$ -24.64M
|
Operating Income / Loss
|
$ -111.93M
|
$ -24.77M
|
$ -26.75M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -55.38M
|
$ -25.65M
|
$ -21.85M
|
PE Ratio
|
|
|
|
Splits |
Sep 14, 2018:
30:1
|
May 05, 2017:
10:1
|
May 04, 2017:
10:1
|
Jul 25, 2007:
50:1
|
|